- Adherence
- Children
- Clinical reviews
- Drug supply
- Guidelines
- Hepatitis and HIV coinfection
- HIV Testing
- Infant feeding
- Laboratory monitoring
- Malaria & HIV
- Neurological problems, including HIV dementia
- Nutrition
- Palliative care
- Prevention
- Prevention of mother-to child transmission
- Scaling up treatment and models of service delivery
- Side-effects
- South Africa
- Starting treatment
- First-line antiretroviral therapy: not as simple as we'd like it to be - 19/06/08
- How to deliver good adherence support: lessons from round the world - 10/9/2007
- WHO to monitor ARV side-effects worldwide - 11/9/2007
- First-line treatment choices proving challenging for African ART programmes - 11/9/2007
- A follow-up on follow-up: shifting to a community-based response to improve retention in care - 31/8/2007
- Patient retention challenges and the need for more active follow-up - 22/3/2007
- Lowering the threshold - Is there a case for re-evaluating eligibility criteria for ART? - 1/11/2006
- Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part One - 27/10/2005
- Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part Two - 27/10/2005
- Immune reconstitution inflammatory syndrome (IRIS) in the developing world - 27/10/2005
- Symptoms versus laboratory monitoring as criteria for starting treatment - 27/10/2005
- Fixed-dose ARV combinations: choices and challenges - 27/10/2005
- Monitoring ARV treatment - 27/10/2005
- Combining ARVs with treatment for tuberculosis - 27/10/2005
- Nevirapine-based fixed-dose combination ARVs - 27/10/2005
- Co-trimoxazole prophylaxis - 27/10/2005
- Stigma
- Task shifting
- Treatment failure
- Tuberculosis
- Viral load testing
Starting treatment
First-line antiretroviral therapy: not as simple as we'd like it to be - 19/06/08
How to deliver good adherence support: lessons from round the world - 10/9/2007
WHO to monitor ARV side-effects worldwide - 11/9/2007
First-line treatment choices proving challenging for African ART programmes - 11/9/2007
A follow-up on follow-up: shifting to a community-based response to improve retention in care - 31/8/2007
Patient retention challenges and the need for more active follow-up - 22/3/2007
Lowering the threshold - Is there a case for re-evaluating eligibility criteria for ART? - 1/11/2006
Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part One - 27/10/2005
Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part Two - 27/10/2005
Immune reconstitution inflammatory syndrome (IRIS) in the developing world - 27/10/2005
Symptoms versus laboratory monitoring as criteria for starting treatment - 27/10/2005
Fixed-dose ARV combinations: choices and challenges - 27/10/2005
Monitoring ARV treatment - 27/10/2005
Combining ARVs with treatment for tuberculosis - 27/10/2005
Nevirapine-based fixed-dose combination ARVs - 27/10/2005
Co-trimoxazole prophylaxis - 27/10/2005
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- Unsuccessful post-exposure prophylaxis may still result in weaker HIV infection and lower viral load
- Jury still out on whether circumcision protects gay men against HIV
- Antiretroviral therapy does not fully reverse impact of HIV on hepatitis C-related cirrhosis
- High early mortality after starting antiretroviral treatment in Africa
- Nobel prize awarded to French discoverers of HIV
- Fall in number of undiagnosed HIV infections in the US
- Resistance to darunavir related to pre-existing mutations
- Higher levels of drug resistance seen after first-line NNRTI failure than boosted PI failure: meta-analysis
- Wide variation found in anal HPV viral loads in HIV-positive men
- Offering rapid point-of-care tests would increase uptake of HIV testing